SK Capital Partners Archives

KeyBanc, Kayne Anderson, Benefit Street Support SK Capital’s Acquisition of J&K Ingredients

Funds advised by SK Capital Partners completed the previously announced acquisition of J&K Ingredients from CORE Industrial Partners. KeyBanc Capital Markets, Kayne Anderson Private Credit and Benefit Street Partners provided debt financing to support the acquisition.

SK Capital Partners Completes Acquisition of Apotex Pharmaceutical Holdings

Apotex Pharmaceutical Holdings’ acquisition by an affiliate of funds advised by SK Capital Partners has closed. The company also appointed Allan Oberman as president and CEO and member of the board of Apotex.

April 4, 2023 Aaron Davenport | Allan Oberman | Apotex Pharmaceutical Holdings | SK Capital Partners Ian Koplin

Jackson Joins SK Capital Partners as Managing Director and Head of Capital Markets

SK Capital Partners hired Richard Jackson as managing director, head of capital markets. Jackson will be based in New York and brings three decades of investment banking and deal making experience across Europe and the U.S. to SK Capital.

May 17, 2022 Jamshid Keynejad | Richard Jackson | SK Capital Partners Ian Koplin

H.I.G. Capital Agrees to Sell Valtris Specialty Chemicals to SK Capital Partners

H.I.G. Capital signed an agreement to sell its portfolio company, Valtris Specialty Chemicals, to an affiliate of funds managed by SK Capital Partners.

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: SK Capital Partners

KeyBanc, Kayne Anderson, Benefit Street Support SK Capital’s Acquisition of J&K Ingredients

SK Capital Partners Completes Acquisition of Apotex Pharmaceutical Holdings

Jackson Joins SK Capital Partners as Managing Director and Head of Capital Markets

H.I.G. Capital Agrees to Sell Valtris Specialty Chemicals to SK Capital Partners